Previous Article | Next Article 
Clinical and Diagnostic Laboratory Immunology, September 2000, p. 828-831, Vol. 7, No. 5
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Evaluation of Primary Binding Assays for
Presumptive Serodiagnosis of Swine Brucellosis in Argentina
P. Silva
Paulo,1,*
A. M.
Vigliocco,1
R. F.
Ramondino,1
D.
Marticorena,1
E.
Bissi,1
G.
Briones,1
C.
Gorchs,1
D.
Gall,2 and
K.
Nielsen2
Comision Nacional de Energia Atomica Centro
Atomico Ezeiza, Ciudad de Buenos Aires,
Argentina,1 and Canadian Food Inspection
Agency, Animal Diseases Research Institute, Nepean, Ontario, Canada K2H
8P92
Received 29 November 1999/Returned for modification 10 March
2000/Accepted 17 May 2000
 |
ABSTRACT |
An indirect enzyme-linked immunosorbent assay (IELISA), a
competitive ELISA (CELISA), and a fluorescence polarization assay (FPA)
for the presumptive serological diagnosis of swine brucellosis were
evaluated using two populations of swine sera: sera from brucellosis-free Canadian herds and sera from Argentina selected based
on positive reactions in the buffered antigen plate agglutination test
(BPAT) and the 2-mercaptoethanol (2-ME) test. In addition, sera from
adult swine from which Brucella suis was isolated at least
once for each farm of origin were evaluated. The IELISA, CELISA, and
FPA specificity values were 99.9, 99.5, and 98.3%, respectively, and
the IELISA, CELISA, and FPA sensitivity values relative to the BPAT and
the 2-ME test were 98.9, 96.6, and 93.8%, respectively. Actual
sensitivity was assessed by using 37 sera from individual pigs from
which B. suis was cultured, and the values obtained were as
follows: BPAT, 86.5%; 2-ME test, 81.1%; IELISA, 86.5%; CELISA,
78.5%; and FPA, 80.0%.
 |
INTRODUCTION |
Brucella suis occurs
naturally in the smooth phase. The smooth Brucella spp.
share certain smooth lipopolysaccharide (SLPS) epitopes, resulting in
extensive serological cross-reactions. For this reason, conventional
serological tests for swine brucellosis use antigens from
Brucella abortus rather than B. suis, as shown by
extensive testing for swine brucellosis in the United States (6). Conventional serological tests (16) and
indirect enzyme-linked immunosorbent assays (IELISAs) (4,
16) cannot identify animals infected with Yersinia
enterocolitica O:9 because of epitopes shared with
Brucella spp. (16), resulting in lower
specificity values than assays such as the competitive ELISA (CELISA)
and the fluorescence polarization assay (FPA), which are capable of distinguishing animals infected with cross-reacting microorganisms (8, 9, 15) or vaccinated with B. abortus strain
19 (11) from animals infected with B. abortus or
B. suis. The specificity of conventional serological
agglutination tests was further reduced by nonspecific antibody thought
to be immunoglobulin M (IgM) (16).
Due to the uncertain nature of serological reactions to
Brucella in pigs, the screening buffered antigen plate
agglutination test (BPAT) (2) and the 2-mercaptoethanol
(2-ME) agglutination test (7) are currently used for the
detection of B. suis in infected herds. Only a few studies
have described the development of primary binding assays for the
detection of antibody to B. suis (17, 20).
More recently the IELISA, the CELISA, and the FPA developed for the
diagnosis of bovine brucellosis (10, 14) have been validated
for the presumptive diagnosis of swine brucellosis (15). The
aims of the present study were to evaluate the IELISA, CELISA, and FPA
for diagnosis of porcine brucellosis in Argentina, compared with the
BPAT and 2-ME test used as diagnostic tests in Argentina, and to
confirm previous data.
 |
MATERIALS AND METHODS |
Negative sera.
Sera from Canadian pigs with no clinical or
epidemiological evidence of brucellosis (B. suis has not
been detected in Canada) were used to evaluate the cutoff values and
specificities for the IELISA, CELISA (n = 952), and FPA
(n = 866).
Positive sera.
Sera with positive reactions in the BPAT and
the 2-ME test were used to evaluate relative sensitivities for the
IELISA, CELISA (n = 469), and FPA (n = 387). All sera that gave positive results were retested using the
IELISA, CELISA, and FPA. Due to insufficient volume, 82 sera were not
tested in the FPA.
Sera from B. suis culture-positive animals.
One
hundred sixty blood samples, as well as retropharyngeal and mandibular
lymph nodes, were simultaneously collected from adult swine at the time
of slaughter. Blood samples were allowed to clot and were centrifuged
and then kept frozen until they were tested. The lymph nodes were cut
into pieces, macerated with a blade, and inoculated directly onto
Farrel's medium. All plates were incubated at 37°C for 8 days.
Colonies suspected of being Brucella were identified by
macroscopic appearance, acriflavin testing, and oxidase and urease
reactions and were biotyped using standard procedures and phagetyped
using Brucella phages (1). Thirty-seven positive
samples were obtained.
Serological tests.
The BPAT and the 2-ME test were performed
according to standard procedures (19). The IELISA, CELISA,
and FPA were performed as described previously (11-13).
Briefly, the IELISA and CELISA used B. abortus SLPS
(12) immobilized on a polystyrene matrix as the antigen.
The IELISA used a monoclonal antibody specific for a heavy-chain
epitope of porcine IgG, labeled with horseradish peroxidase
(
12), as the detection reagent. The dilution of serum for
this
assay was 1:50. Optical density values were obtained after 10
min
of incubation with the substrate-chromogen system, and the
data were
presented as a percentage of the strong positive control
serum included
in each plate (%P).
The CELISA used a monoclonal antibody specific for an epitope of
B. abortus O-polysaccharide (
12) as the
competition reagent
and a goat anti-mouse IgG (H- and L-chain-specific)
affinity-purified
antibody-enzyme conjugate (Jackson ImmunoResearch
Laboratories,
Inc., West Grove, Pa.) as the detection reagent. For this
assay,
the final serum dilution was 1:20. Optical density values were
determined after 10 min of incubation with the substrate-chromogen,
and
the data were expressed as a percentage of inhibition (%I)
relative to
the optical density of the buffer control (no inhibition
control).
The FPA used the
O-polysaccharide prepared from
B. abortus SLPS conjugated with fluorescein isothiocyanate as a
tracer (
13).
Each porcine serum, diluted 1:25, was evaluated
in a fluorescence
polarization analyzer (FPM-1; Jolley Consulting and
Research,
Round Lake, Ill.) to obtain a background reading. Then tracer
was added to each sample and mixed, and the mixture was incubated
for
at least 2 min. A second reading was obtained in millipolarization
units (mP). The millipolarization units indicate the level of
antibodies in the serum (the blank is automatically substracted
from
each sample); a value higher than the cutoff value was considered
positive.
Data analysis.
The ability of the IELISA, CELISA, and FPA to
discriminate positive sera from negative sera was evaluated using
receiver operating characteristics (ROC) analysis (18). ROC
software determines all possible sensitivity-specificity pairs with
associated cutoffs, including the optimal values for each assay. Use of
the ROC curve allows comparison of different tests without the problems
of arbitrariness inherent in single calculations of
sensitivity-specificity pairs (3). The optimal cutoff values
were used to compare the tests. ROC analysis was also used to determine
the area under the curve (AUC), a measure of test accuracy. For
example, an AUC of 0.95 indicates that a randomly selected individual
animal from a positive population will have a test result value greater
than a randomly selected individual animal from a negative population
95% of the time.
 |
RESULTS |
The cutoff values for the IELISA, CELISA, and FPA were 26%P,
29%I, and 87.7 mP, respectively (Fig.
1). Using these cutoff values, the
sensitivity values relative to the BPAT and the 2-ME test for the
IELISA, CELISA, and FPA were 98.9, 96.6, and 93.8%, respectively. The
specificity values for the IELISA, CELISA, and FPA were 99.9, 99.5, and
98.3%, respectively. B. suis was isolated from 37 of 160 slaughtered pigs tested. Twenty-eight isolates were typed as B. suis biovar 1 (atypical), and nine were B. suis biovar
1 (5). Three of 37 sera from positive-culture pigs gave negative serological reactions in all tests (Table
1). The actual sensitivity values, based
on 37 sera from which B. suis had been isolated, for the
BPAT, 2-ME test, IELISA, CELISA, and FPA were 86.5 (32 of 37), 81.1 (30 of 37), 86.5 (32 of 37), 78.5 (29 of 37), and 80.0% (28 of 35),
respectively.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 1.
ROC analysis, plotting percent sensitivity (y
axis) against 100 percent specificity (x axis) in
the IELISA, CELISA, and FPA.
|
|
The AUCs for the IELISA, CELISA, and FPA were 0.995, 0.979, and 0.976, respectively. This shows that in more than 97% of cases an animal
giving a result above the cutoff value was correctly identified (Fig.
1).
 |
DISCUSSION |
Conventional serological tests are not reliable for the
presumptive diagnosis of porcine brucellosis in individual animals (16). The BPAT is prescribed by the Office International des Epizooties and is widely used as a screening test; however, its sensitivity and specificity are generally considered low
(16). The complement fixation test is not considered
suitable for individual animal testing, since swine complement
interacts with guinea pig complement, reducing the sensitivity of the
test (16). The 2-ME test is not included in the Office
International des Epizooties manual. A general problem with all
conventional tests and some primary binding assays is that they detect
antibody resulting from exposure to cross-reacting organisms, such as
Y. enterocolitica O:9, a problem in some areas (4,
21). This is demonstrated by data found at the Statens
Veterinaere Serumlaboratorium, Copenhagen, Denmark, website
(http://www.svs.dk/dk/ye-rapp.htm) showing that the complement
fixation test does not distinguish between antibodies produced by
Y. enterocolitica O:9 and antibodies produced by B. suis or B. abortus in 70% of the sera tested while the
CELISA was positive in only 14% of the cases.
IELISAs have been developed, and while their sensitivities and
specificities are higher than those of the conventional tests, they
still detect antibody to cross-reacting microorganisms, such as
Y. enterocolitica O:9 (4, 16). This explains why
the relative sensitivity and actual sensitivity in this study surpassed
those of other primary binding assays, as shown in another study
(15).
The CELISA and FPA have been shown to decrease the frequency with which
vaccinal and cross-reacting antibody is detected in cattle, with the
FPA performing slightly better (11, 14). Since the
parameters for these assays are similar when testing porcine sera, it
would be reasonable to infer that interfering antibody may be
eliminated in some cases, resulting in more specific assays. In a
previous study the CELISA, correlated highly with combined BPAT and
2-ME test results (A. M. Vigliocco, D. Marticorena, R. Ramondino,
P. Silva Paulo, C. Briones, E. Bisi, and K. Nielsen, Abstr. Int. Symp.
Dis. Control 21st Century, abstr IAEA-SM348/34p, p. 77, 1997). This is
also the case in the current study, resulting in specificity and
relative sensitivity values of 99.5 and 96.6% for the CELISA. Both the
FPA and the CELISA gave very similar results, with the IELISA
performing marginally better in this study, as in a previous study
(15). In the FPA, the data may have been influenced by using
freeze-dried sera for the negative population. Freeze-dried sera
frequently do not completely dissolve when reconstituted, and sizeable
complexes may remain, causing elevation of the millipolarization units
for negative sera, thereby decreasing the assay sensitivity.
A problem with using conventional tests to validate new tests is that
inaccuracies in the former are considered as failure of the latter.
Thus, defined sera obtained from animals with proven infection would be
ideal, but only small numbers of such sera were available for this
study. In the current study, 37 sera from pigs from which B. suis was cultured were used to decide the actual sensitivity. Of
the 37 sera, 3 were negative in all tests, 5 were negative on the BPAT
and IELISA, 7 were negative on the 2-ME test and FPA (two fewer animals
were tested due to insufficient serum), and 8 were negative on the
CELISA (Table 1), resulting in low actual sensitivity values. This may
be due to selection techniques, such as the use of pigs 2 to 3 months
of age, which are susceptible to infection with B. suis but
have very limited ability to produce antibody (16). There
may also be a lack of antibody response in the very early stages of
infection, or seronegative animals may have been infected without
exhibiting any serological or clinical evidence of infection
(21). The actual sensitivity values were close, due to the
small sample set, and predicting which test would be more accurate
would be difficult. In comparison, the actual sensitivity values
obtained in a larger study (15) for the BPAT, IELISA,
CELISA, and FPA were 77.1, 94.0, 90.8, and 93.5% with sera from 401 pigs infected with B. suis from Argentina, Chile, Mexico,
and the United States. The small data set has shown that culture
results in the current study may be biased due to insufficient numbers
and selection of animals exhibiting clinical signs.
The relative sensitivity values of the IELISA, CELISA, and FPA in the
current study were 98.9, 96.6, and 93.8%, respectively, indicating
that the relative sensitivity values were as good as the actual
sensitivities achieved in the larger study with culture-positive pigs
(15). The specificity values in this study for the IELISA, CELISA, and FPA were 99.9, 99.5, and 98.3%, respectively, which was
better than the specificity values achieved in the larger study
(15) using 14,037 sera from a Canadian national survey performed in 1997. The specificity values for the IELISA, CELISA, and
FPA in this larger study were 97.8, 96.6, and 97.2%, respectively. Since the BPAT and the 2-ME test are considered inaccurate in the
diagnosis of porcine brucellosis, the estimates of sensitivity and
specificity for the IELISA, CELISA, and FPA will be biased. The effect
of this bias will be to inflate the relative sensitivity and
specificity values for the IELISA, CELISA, and FPA, since they will be
correlated with the BPAT and 2-ME test (3). This may explain
why the relative sensitivity and specificity values for the IELISA,
CELISA, and FPA are higher in this study than in the larger study.
For a new test for the presumptive diagnosis of brucellosis to be
accepted, it would be required to perform as well as or better than the
tests in use or to possess an advantageous attribute. The data reported
for the diagnosis of B. suis in swine in this study show
that the IELISA appeared to perform slightly better than the CELISA or
FPA for sensitivity relative to the 2-ME test or the actual sensitivity
based on culture results. However, the IELISA cannot differentiate
antibody to cross-reacting microorganisms, such as Y. enterocolitica O:9, from antibody to B. abortus. Both the CELISA and the FPA have this capability. The ability to
differentiate is important, since yersinosis sometimes occurs in pigs
(4). The CELISA is more complex and labor-intensive than the
FPA, which is a very simple and inexpensive test compared with the
IELISA and CELISA. It has the added advantage of adaptability to use outside the laboratory setting. The relative sensitivity and
specificity obtained in this study exceed the actual sensitivity and
specificity in a larger study, indicating that its performance is
consistent with the that shown in the larger study (15). The
actual sensitivity obtained in the larger study (n = 401) was significantly higher than the actual sensitivity obtained
in this study due to the small sampling size (n = 37).
 |
ACKNOWLEDGMENTS |
This project was supported in part by the National Agency for
Promoting Science and Technology (Argentina) Project 08-04311 and by
the Canadian Food Inspection Agency.
We acknowledge Norma Pereyra and Fernando Cane (Instituto de
Porcinotecnia, Chanar Ladeado, Pcia de Santa Fe, Argentina) for the
sera supplied.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Comision
Nacional de Energia Atomica Centro Atomico Ezeiza, Av. del Libertador
8250, CP 1429, Ciudad de Buenos Aires, Argentina. Phone:
54-11-4379-8531. Fax: 54-11-4379-8540. E-mail:
silvapau{at}cae.cnea.gov.ar.
 |
REFERENCES |
| 1.
|
Alton, G. G.,
L. M. Jones,
R. D. Angus, and J. M. Verger.
1988.
Techniques for the brucellosis laboratory, p. 13-61.
Institut National de la Recherche Agronomique, Paris, France.
|
| 2.
|
Angus, R. D., and C. E. Barton.
1984.
The production and evaluation of a buffered plate antigen for use in a presumptive test for brucellosis.
Dev. Biol. Stand.
56:349-356[Medline].
|
| 3.
|
Begg, C. B.
1987.
Biases in the assessment of diagnostic tests.
Stat. Med.
4:411-423.
|
| 4.
|
Corbel, M. J.
1985.
Recent advances in the study of Brucella antigens and their serological cross reactions.
Vet. Bull.
55:927-941.
|
| 5.
|
Corbel, M. J.,
E. L. Thoma, and C. Garcia Carrillo.
1984.
Taxonomic studies on some atypical strains of Brucella suis (1984).
Br. Vet. J.
140:33-43.
|
| 6.
|
Deyoe, B. L.
1987.
In
A. D. Leman, B. Straw, R. D. Glock, W. L. Mengelin, R. H. C. Penny, and E. Scholl (ed.), Diseases of swine, 6th ed.
Iowa State University Press, Ames.
|
| 7.
|
Garcia Carrillo, C.,
V. Cedro, and L. De Benedetti.
1971.
Evaluación de técnicas serológicas en cerdos con infección reciente de Brucella suis., vol. serie 4, vol. VIII, no. 4. , p. 99-107.
Revista de Investigaciones Agropecuarias, INTA, Republica Argentina.
|
| 8.
|
Nielsen, K.,
J. W. Cherwonogrodzky,
R. J. Duncan, and D. R. Bundle.
1989.
Enzyme-linked immunosorbent assay for differentiation of the antibody response of cattle naturally infected with Brucella abortus or vaccinated with strain 19.
Am. J. Vet. Res.
50:5-9[Medline].
|
| 9.
|
Nielsen, K.
1990.
The serological response of cattle immunized with Yersinia enterocolitica O:9 or O:16 to Yersina and Brucella abortus antigens in enzyme immunoassays.
Vet. Immunol. Immunopathol.
24:373-382[CrossRef][Medline].
|
| 10.
|
Nielsen, K.,
D. Gall,
W. A. Kelly,
D. Henning, and M. Garcia.
1992.
Enzyme immunoassay: application to diagnosis of bovine brucellosis.
Agriculture Canada, Nepean, Canada.
|
| 11.
|
Nielsen, K.,
L. Kelly,
D. Gall,
S. Balsevicius,
P. Nicolleti, and W. Kelly.
1995.
Improved competitive enzyme immunoassays for the diagnosis of bovine brucellosis.
Vet. Immunol. Immunopathol.
46:285-291[CrossRef][Medline].
|
| 12.
|
Nielsen, K.,
D. Gall,
A. Kelly,
A. Vigliocco,
D. Henning, and M. Garcia.
1996.
Immunoassay development application to enzyme immunoassays for the diagnosis of brucellosis.
Agriculture and Agri-Food Canada, Nepean, Canada.
|
| 13.
|
Nielsen, K.,
D. Gall,
M. Jolley,
G. Leishman,
S. Balsevicius,
P. Smith,
P. Nicoletti, and F. Thomas.
1996.
Homogeneous fluorescence polarization assay for detection of antibody to Brucella abortus.
J. Immunol. Methods
195:161-168[CrossRef][Medline].
|
| 14.
|
Nielsen, K.,
D. Gall,
M. Lin,
C. Massangill,
L. Samartino,
B. Perez,
M. Coats,
S. Henager,
A. Dajer,
P. Nicoletti, and F. Thomas.
1998.
Diagnosis of bovine brucellosis using a homogeneous fluorescence polarization assay.
Vet. Immunol. Immunopathol.
66:321-329[CrossRef][Medline].
|
| 15.
|
Nielsen, K.,
D. Gall,
P. Smith,
A. Vigliocco,
B. Perez,
L. Samartino,
P. Nicoletti,
A. Dajer, and F. Enright.
1999.
Validation of the fluorescence polarization assay as a serological test for the presumptive diagnosis of porcine brucellosis.
Vet. Microbiol.
68:245-253[CrossRef][Medline].
|
| 16.
|
Office International des Epizooties.
1996.
Manual of standards for diagnostic tests and vaccines, p. 471.
Office International des Epizooties, Paris, France.
|
| 17.
|
Priadi, A.,
V. Casanah,
R. G. Hirst,
J. J. Emmins,
J. van der Giessen, and M. Soeroso.
1986.
Development of an enzyme-linked immunosorbent assay (ELISA) for detecting antibody to Brucella suis in porcine sera, abstr. 7528.
Vet. Bull.
56:967. (Abstract.)
|
| 18.
|
Schoojans, F.,
A. Zalata,
C. E. Depuydt, and F. H. Comhaire.
1995.
MedCalc: a new computer program for medical statistics.
Comput. Methods Programs Biomed.
48:257-262[CrossRef][Medline].
|
| 19.
|
Servicio Nacional de Sanidad Animal.
1993.
Procedure manual: serological diagnosis of bovine brucellosis.
Servicio Nacional de Sanidad Animal., Buenos Aires, Argentina.
|
| 20.
|
Thoen, C. O.,
M. P. Hopkins,
A. L. Armbrust,
R. D. Angus, and D. E. Pietz.
1980.
Development of an enzyme-linked immunosorbent assay for detecting antibodies in sera of Brucella suis infected swine.
Can. J. Comp. Med.
44:294-298[Medline].
|
| 21.
|
Van Aert, A.,
P. Brioen,
P. Dekeyser,
L. Uytterhaegen,
R. J. Sijens, and A. Boeyé.
1984.
A comparative study of ELISA and other methods for the detection of Brucella antibodies in bovine sera.
Vet. Microbiol.
10:13-21[CrossRef][Medline].
|
| 22.
|
Wrathall, A. E.,
E. S. Broughton,
K. P. W. Gill, and G. P. Goldsmith.
1993.
Serological reactions to Brucella species in British pigs.
Vet. Rec.
132:449-454[Abstract].
|
Clinical and Diagnostic Laboratory Immunology, September 2000, p. 828-831, Vol. 7, No. 5
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.